Female Leadership in the Tech 100 Cohort
A diverse innovation landscape
The cohort spans:
Together, they illustrate the increasing diversity of leadership across the Tech 100 in background and expertise, as well as geography, sector focus and route to scale.
Antibody therapeutics
Founded in 2019, Alchemab specialises in identifying naturally occurring protective antibodies in individuals resilient to disease. Co‑founder and CEO Jane Osbourn OBE brings deep biologics expertise, with the company pursuing therapies across oncology, neurodegeneration and infectious diseases.
Neurodegenerative disease therapeutics
Led by neuroscientist Jane Rhodes, AstronauTx is developing novel treatments to restore healthy brain function in conditions such as Alzheimer’s. The company stands out for its differentiated scientific approach in a challenging therapeutic area.
Semiconductors – Gallium Nitride power devices
Spun out of Cambridge University, Cambridge GaN Devices (CGD) develops high‑efficiency GaN power semiconductors that reduce energy loss across power electronics. Co‑founder Dr Giorgia Longobardi is an internationally recognised leader in GaN technology.
Investigation and intelligence software
Under CEO Clare Elford, Clue has scaled into a provider of mission‑critical investigation management software used by law enforcement, regulators and corporates, reflecting growing demand for secure intelligence platforms.
Biotech
Founded in 2021, Draig Therapeutics focuses on accelerating innovative therapeutic development. CEO Ivana Magovcevic Liebisch brings extensive global biotech leadership experience, supporting the company’s rapid early progress.
AI‑driven fieldwork and operations platform
Co‑founded by CEO Shelley Copsey, FYLD applies AI and real‑time analytics to improve safety and productivity in infrastructure and utilities. The platform demonstrates the growing commercial adoption of applied AI beyond traditional tech sectors.
Nature intelligence and biodiversity data
Led by CEO Dimple Patel, NatureMetrics is a global pioneer in environmental DNA (eDNA) analysis, providing biodiversity data to corporates, governments and conservation groups as demand for measurable nature insights accelerates.
Cross Sector Themes
Across the cohort, several consistent characteristics emerge:
These attributes reinforce the strength and resilience of female led businesses operating at the cutting edge of innovation.
Explore more from the Tech 100
Whether in the early phases of gaining commercial traction, funding and scaling, or approaching an exit, there are common challenges that growth company leaders confront.
… and more
A set of thematic insights exploring the sectors shaping UK innovation – from media and hardware to industrials, life sciences and healthtech.
Each piece highlights key trends, market dynamics and business models seen across this year’s fastest‑growing tech companies.
An interactive workshop blending early‑stage considerations with practical guidance to help you plan with confidence.
Our investment banking, research and sales teams will share a rounded view of the IPO process, life as a listed company, what it means to be ‘investor ready’, and the key early decisions that matter.
